Benzinga's Top Upgrades, Downgrades For May 30, 2017

Top Upgrades

• Analysts at Piper Jaffray upgraded Zynga Inc ZNGA from Neutral to Overweight. Zynga shares gained 2.3 percent to $3.57 in pre-market trading.
• Goldman Sachs upgraded AutoZone, Inc. AZO from Neutral to Buy. AutoZone shares rose 1.2 percent to $623.00 in pre-market trading.
• Analysts at Baird upgraded First Bank FRBA from Neutral to Outperform. First Bank shares rose 2.6 percent to $12.00 in pre-market trading.
• Analysts at JP Morgan upgraded Teck Resources Ltd (USA) TECK from Neutral to Overweight. Teck Resources shares gained 0.81 percent to close at $18.71 on Friday.
• Susquehanna upgraded Caleres Inc CAL from Neutral to Positive. Caleres shares climbed 9.11 percent to close at $27.08 on Friday.
• Analysts at Barclays upgraded Symantec Corporation SYMC from Equal-Weight to Overweight. Symantec shares fell 1.14 percent to close at $29.61 on Friday.
• Stifel Nicolaus upgraded Hub Group Inc HUBG from Hold to Buy. Hub Group shares gained 1.61 percent to close at $34.65 on Friday.
• Goldman Sachs upgraded Newfield Exploration Co. NFX from Neutral to Buy. Newfield Exploration shares rose 0.42 percent to $33.22 in pre-market trading.
• Morgan Stanley upgraded Tesoro Corporation TSO from Equal-Weight to Overweight. Tesoro shares dropped 0.88 percent to close at $83.46 on Friday.

Top Downgrades

• Goldman Sachs downgraded Whiting Petroleum Corp WLL from Neutral to Sell. Whiting Petroleum shares fell 4.02 percent to $7.65 in pre-market trading.
• Mizuho downgraded Macerich Co MAC from Buy to Neutral. Macerich shares fell 2.33 percent to close at $58.77 on Friday.
• Wedbush downgraded Buffalo Wild Wings BWLD from Neutral to Underperform. Buffalo Wild Wings shares fell 2.1 percent to $147.80 in pre-market trading.
• Pacific Crest downgraded Ambarella Inc AMBA from Overweight to Sector Weight. Ambarella shares fell 4.7 percent to $62.00 in pre-market trading.
• Morgan Stanley downgraded Valero Energy Corporation VLO from Overweight to Equal-Weight. Valero Energy shares fell 0.45 percent to $62.17 in pre-market trading.
• Wedbush downgraded AutoZone, Inc. AZO from Outperform to Neutral. AutoZone shares rose 0.39 percent to $618.00 in pre-market trading.
• Raymond James downgraded BlackBerry Ltd BBRY from Outperform to Market Perform. BlackBerry shares slipped 0.99 percent to $11.00 in pre-market trading.

Top Initiations

• Analysts at Raymond James initiated coverage of Antero Midstream GP LP AMGP with a Strong Buy rating. The price target for Antero Midstream is set to $26. Antero Midstream shares closed at $21.97 on Friday.
• William Blair initiated coverage of Ovid Therapeutics Inc OVID with an Outperform rating. Ovid Therapeutics shares closed at $14.48 on Friday.
• Analysts at Independent Research initiated coverage on Tesla Inc TSLA with a Hold rating. The price target for Tesla is set to $350. Tesla shares closed at $325.14 on Friday.
• Citigroup initiated coverage on Keysight Technologies Inc KEYS with a Buy rating. The price target for Keysight Technologies is set to $44. Keysight Technologies shares closed at $38.36 on Friday.
• Analysts at Rodman & Renshaw initiated coverage on Pieris Pharmaceuticals Inc PIRS with Buy rating. The price target for Pieris Pharmaceuticals is set to $9. Pieris Pharmaceuticals shares closed at $4.31 on Friday.
• Analysts at Monness Crespi Hardt initiated coverage on Rapid7 Inc RPD with a Buy rating. The price target for Rapid7 is set to $23. Rapid7 shares closed at $17.82 on Friday.
• JP Morgan initiated coverage on KKR Real Estate Finance Trust Inc KREF with a Neutral rating. The price target for KKR Real Estate Finance Trust is set to $23. KKR Real Estate Finance Trust shares closed at $22.80 on Friday.
• Cowen & Co. initiated coverage on Urogen Pharma Ltd URGN with an Outperform rating. Urogen Pharma shares closed at $18.48 on Friday.
• Analysts at Stifel Nicolaus initiated coverage on DXC Technology Company DXC with a Hold rating. The price target for DXC Technology is set to $86. DXC Technology shares closed at $78.66 on Friday.
• Barclays initiated coverage on Biohaven Pharmaceutical Holding Co Ltd BHVN with an Overweight rating. The price target for Biohaven Pharmaceutical is set to $30. Biohaven Pharmaceutical shares closed at $23.79 on Friday.